الابحاث

South Egypt Cancer Institute

Assiut University

Department of Medical Oncology
# Title Research Member Research Year
11 Predictive Factors for Site of Local and Systemic Recurrence in Breast Cancer Patients Manal Mamdouh Mohamed Ali 2025
12 Non-Metastatic Triple Negative Breast Cancer with Neuroendocrine Differentiation: Survival Parameters Dr. Salah Mabrouk Khallaf Abd Rabou 2025
13 Assessment of Response to Hormonal Therapy by Serum Ki-67 as a Biomarker in Non-metastatic Hormone Positive Breast Cancer Zeina Omar Attia Sayed 2024
14 Prognostic Value of Erythropoietin-Producing Hepatocellular Receptor A2 (Epha2) Serum Marker in Colorectal Cancer Dr. Asmaa Mohamed Zahran Omar 2024
15 The transcription factor ZEB-1 conveys chemoresistance in breast cancer Samar Abotaleb Mahmou 2024
16 Prognostic Value of Erythropoietin-Producing Hepatocellular Receptor A2 (Epha2) Serum Marker in Colorectal Cancer Dr. Amen Hamdy Zaki Ali 2024
17 Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line Amany Mohammed Abdel Moatamed 2024
18 Prognostic Value of Erythropoietin-Producing Hepatocellular Receptor A2 (Epha2) Serum Marker in Colorectal Cancer Dr. Hanaan Ahmed Mohammed Ahmed 2024
19 Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line Dr. Salah Mabrouk Khallaf Abd Rabou 2024
20 Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line Dr. Shimaa Hassan Shabaan Hassan 2024